New Products & Updates

Product Name: Format/SizeDescriptionsDownload
Signature Libraries4800 compounds
Release: 2015-2016
Update: 2016-10
ASINEX's cutting edge chemistry combined with in silico and in vitro screening validation. Favorable results are packaged in an easy to use, one plate format (80 compounds). For more information, please download >>>

List of all "Signature Libraries" pleaseclick here.
sdf-icon pdf-icon
Macrocycle Pre-Plated Set22957 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2017-03
ASINEX ‘s Macrocycle Pre-plated Sets are designed to provide the most popular screening libraries in a convenient and cost-effective manner. For more information, please download >>>sdf-icon pdf-icon
PPI Pre-Plated Set8637 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2017-03
ASINEX has been working on the design and synthesis of protein-protein interaction (PPI) libraries since 2008. The latest generation of ASINEX PPI Library comprises molecules of various sizes, frameworks, and shapes ranging from fragment-like entities to macrocyclic derivatives designed as secondary structure mimetics or as epitope mimetics. For more information, please download >>>sdf-icon pdf-icon
Glycomimetics Pre-Plated Set2439 compounds
Pre-Plated Set
Amount: 0.01-2.0 mg
Update: 2017-03
ASINEX has overcome these obstacles by creating a glycomimetic library that ensures the bioactive function of carbohydrates while addressing the drawbacks of carbohydrates, such as their low activity and poor drug-like properties. For more information, please download >>>sdf-icon pdf-icon

News & Events

Drug Discovery Chemistry 2017
San Diego, CA / April 23-27
ASINEX is the premier sponsor of theDrug Discovery ChemistryConference scheduled to take place at the Sheraton San Diego Hotel & Marina from April 23-27.

ASINEX will also be involved in a panel discussion in the Macrocyclics & Constrained Peptides track and as the premier sponsor is able to offerFREE ATTENDANCE (click here)to this event for the winner of a contest. Please enter this contest for the chance to attend this event FREE!

Additionally, ASINEX is hosting a round table “breakout discussion” on the morning of Tuesday, April 25.

Title: Identifying the Best Starting Point in PPI Drug Discovery

• Should one consider a collection of fragments, “traditional” small molecules, macrocycles, or any other screening collection?
• Is a high throughput, medium throughput, or SBDD the best approach?
• Are “difficult” targets becoming easier?

Questions/comments on this event and your possibleFREE ATTENDANCEcan be referred to Mark Parisi at MParisi@asinex.com.

 

Top